Share Price and Basic Stock Data
Last Updated: November 8, 2025, 5:53 am
| PEG Ratio | -7.24 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
BASF India Ltd operates within the chemicals sector, focusing on organic products. As of the most recent reporting, the company’s share price stood at ₹4,438, with a market capitalization of ₹19,208 Cr. The revenue from operations for the trailing twelve months was reported at ₹14,947 Cr, reflecting a consistent upward trend from ₹13,100 Cr in FY 2022 to ₹13,645 Cr in FY 2023. Quarterly sales figures indicate fluctuations, with a peak of ₹4,248 Cr anticipated in September 2024, although the most recent quarter recorded sales of ₹3,707 Cr in September 2023. This performance showcases the company’s ability to generate significant revenue, although the quarterly variations suggest challenges in maintaining consistent growth. The operating profit margins (OPM) have fluctuated around 5-8%, with a recent OPM of 5.45% for FY 2025, indicating potential operational challenges amid rising costs. Overall, the revenue trend reflects a solid demand base but highlights the need for improved operational efficiency to stabilize margins.
Profitability and Efficiency Metrics
The profitability metrics of BASF India demonstrate a mixed performance. The net profit for FY 2025 was reported at ₹499 Cr, down from ₹563 Cr in FY 2024, which corresponds to a net profit margin of 3.29% for the same period. This decline in profitability raises concerns regarding cost management amid rising operational expenses, which have increased from ₹12,188 Cr in FY 2022 to ₹14,415 Cr in FY 2025. The company’s return on equity (ROE) stood at 13.7%, while the return on capital employed (ROCE) was reported at 18.0%. These figures indicate a moderately efficient use of equity and capital, particularly in comparison to industry averages, which often hover around 15-20% for ROCE. Additionally, the interest coverage ratio (ICR) at 53.17x reflects a robust capacity to service debt, a critical factor in maintaining financial stability. However, the decline in OPM to 5.45% in FY 2025 highlights the need for enhanced operational efficiency to bolster profitability.
Balance Sheet Strength and Financial Ratios
BASF India’s balance sheet exhibits a solid foundation, characterized by total assets of ₹8,330 Cr and reserves amounting to ₹3,614 Cr as of FY 2025. The company’s borrowings were relatively low at ₹157 Cr, which enhances its financial flexibility and reduces interest burden, evidenced by an impressive interest coverage ratio of 53.17x. The current ratio stood at 1.55, indicating adequate liquidity to meet short-term obligations. However, the quick ratio at 0.92 suggests potential liquidity challenges when inventory is excluded, which may raise concerns in a volatile market. The company’s price-to-book value (P/BV) ratio was reported at 5.25x, indicating that the stock might be priced at a premium relative to its book value, a common phenomenon in high-growth sectors. The enterprise value (EV) of ₹18,377 Cr, relative to net operating revenue (1.21x), suggests that the market is valuing the company favorably compared to its operational earnings, reflecting investor confidence in its growth prospects.
Shareholding Pattern and Investor Confidence
The shareholding pattern of BASF India indicates a strong promoter commitment, with promoters holding 73.33% of the total shares as of March 2025. This predominant stake provides stability and aligns management interests with those of shareholders. However, foreign institutional investors (FIIs) hold a modest 4.21% stake, which raises questions about global investor confidence in the company. Domestic institutional investors (DIIs) have a slightly higher stake at 6.31%, contributing to a balanced institutional presence. The total number of shareholders increased to 64,780 by June 2025, indicating growing retail interest. However, the declining trend in public shareholding from 17.69% in September 2022 to 16.14% in June 2025 may suggest a shift in investor sentiment, which could impact liquidity. Overall, the strong promoter holding and increasing shareholder base reflect solid investor confidence, notwithstanding the need for broader institutional interest to enhance market perception.
Outlook, Risks, and Final Insight
The outlook for BASF India remains cautiously optimistic, given its strong market position and solid financial metrics. However, ongoing fluctuations in quarterly revenue and declining profit margins pose significant risks. The company’s ability to manage operational costs effectively while maintaining sales growth will be crucial in the face of rising expenses. Market volatility and potential regulatory changes in the chemicals sector could further impact profitability. Strengths include a robust interest coverage ratio and strong promoter backing, which provide a cushion against financial stress. Conversely, risks such as declining public shareholding and potential liquidity challenges indicated by the quick ratio must be monitored closely. In scenarios where operational efficiencies are improved and costs are controlled, BASF India could see a rebound in profitability, potentially enhancing shareholder returns and market confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of BASF India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 123 Cr. | 345 | 456/255 | 127 | 390 | 0.03 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,920 Cr. | 9,990 | 14,250/8,150 | 57.3 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 37.5 Cr. | 125 | 329/114 | 15.1 | 24.9 | 0.80 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 35.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 256 Cr. | 320 | 385/163 | 19.8 | 94.6 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,377.14 Cr | 1,665.31 | 405.64 | 330.79 | 0.36% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,888 | 3,582 | 2,898 | 3,277 | 3,375 | 3,707 | 3,326 | 3,360 | 3,967 | 4,248 | 3,759 | 3,189 | 3,752 |
| Expenses | 3,577 | 3,394 | 2,843 | 3,143 | 3,177 | 3,473 | 3,114 | 3,114 | 3,654 | 4,047 | 3,588 | 3,126 | 3,530 |
| Operating Profit | 311 | 188 | 55 | 134 | 198 | 234 | 212 | 246 | 312 | 201 | 170 | 63 | 222 |
| OPM % | 8% | 5% | 2% | 4% | 6% | 6% | 6% | 7% | 8% | 5% | 5% | 2% | 6% |
| Other Income | 3 | 10 | 12 | 27 | 9 | 16 | 27 | 25 | 36 | 18 | 19 | 43 | 21 |
| Interest | 5 | 4 | 3 | 2 | 8 | 2 | 3 | 3 | 5 | 3 | 4 | 4 | 5 |
| Depreciation | 45 | 45 | 46 | 47 | 47 | 47 | 49 | 48 | 47 | 45 | 48 | 38 | 38 |
| Profit before tax | 264 | 149 | 18 | 112 | 152 | 200 | 187 | 219 | 297 | 171 | 138 | 64 | 201 |
| Tax % | 26% | 24% | 41% | 27% | 26% | 26% | 25% | 26% | 26% | 25% | 25% | 27% | 27% |
| Net Profit | 197 | 113 | 11 | 82 | 113 | 149 | 140 | 162 | 221 | 128 | 104 | 47 | 147 |
| EPS in Rs | 45.45 | 26.13 | 2.46 | 19.03 | 26.03 | 34.45 | 32.36 | 37.31 | 50.96 | 29.56 | 23.93 | 10.88 | 34.00 |
Last Updated: August 1, 2025, 11:30 pm
Below is a detailed analysis of the quarterly data for BASF India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 3,752.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,189.00 Cr. (Mar 2025) to 3,752.00 Cr., marking an increase of 563.00 Cr..
- For Expenses, as of Jun 2025, the value is 3,530.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,126.00 Cr. (Mar 2025) to 3,530.00 Cr., marking an increase of 404.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 222.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Mar 2025) to 222.00 Cr., marking an increase of 159.00 Cr..
- For OPM %, as of Jun 2025, the value is 6.00%. The value appears strong and on an upward trend. It has increased from 2.00% (Mar 2025) to 6.00%, marking an increase of 4.00%.
- For Other Income, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 22.00 Cr..
- For Interest, as of Jun 2025, the value is 5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 38.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 38.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 201.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 201.00 Cr., marking an increase of 137.00 Cr..
- For Tax %, as of Jun 2025, the value is 27.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00%.
- For Net Profit, as of Jun 2025, the value is 147.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2025) to 147.00 Cr., marking an increase of 100.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 34.00. The value appears strong and on an upward trend. It has increased from 10.88 (Mar 2025) to 34.00, marking an increase of 23.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 22, 2025, 5:28 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,430 | 4,706 | 4,749 | 5,073 | 5,583 | 6,026 | 7,595 | 9,558 | 13,100 | 13,645 | 13,767 | 15,162 | 14,947 |
| Expenses | 4,146 | 4,572 | 4,642 | 4,802 | 5,238 | 5,861 | 7,316 | 8,926 | 12,188 | 12,958 | 12,878 | 14,415 | 14,291 |
| Operating Profit | 284 | 133 | 107 | 271 | 346 | 165 | 279 | 633 | 911 | 687 | 890 | 747 | 656 |
| OPM % | 6% | 3% | 2% | 5% | 6% | 3% | 4% | 7% | 7% | 5% | 6% | 5% | 4% |
| Other Income | -3 | 39 | 173 | 27 | 182 | 139 | -4 | 419 | 37 | 53 | 76 | 116 | 101 |
| Interest | 16 | 96 | 148 | 142 | 113 | 85 | 83 | 38 | 17 | 14 | 16 | 16 | 15 |
| Depreciation | 71 | 142 | 163 | 169 | 153 | 147 | 181 | 174 | 171 | 182 | 191 | 178 | 169 |
| Profit before tax | 194 | -66 | -30 | -12 | 261 | 72 | 10 | 840 | 760 | 543 | 759 | 670 | 574 |
| Tax % | 34% | 2% | 0% | 13% | 6% | -14% | -131% | 34% | 22% | 26% | 26% | 25% | |
| Net Profit | 128 | -67 | -30 | -14 | 246 | 82 | 23 | 553 | 595 | 403 | 563 | 499 | 426 |
| EPS in Rs | 29.54 | -15.46 | -7.02 | -3.26 | 56.95 | 18.88 | 5.28 | 127.67 | 137.42 | 93.08 | 130.15 | 115.33 | 98.37 |
| Dividend Payout % | 14% | -26% | -14% | -31% | 5% | 26% | 57% | 8% | 4% | 9% | 12% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -152.34% | 55.22% | 53.33% | 1857.14% | -66.67% | -71.95% | 2304.35% | 7.59% | -32.27% | 39.70% | -11.37% |
| Change in YoY Net Profit Growth (%) | 0.00% | 207.57% | -1.89% | 1803.81% | -1923.81% | -5.28% | 2376.30% | -2296.75% | -39.86% | 71.97% | -51.07% |
BASF India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 58% |
| 3 Years: | -7% |
| TTM: | -38% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 26% |
| 3 Years: | 13% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 14% |
Last Updated: September 5, 2025, 12:40 am
Balance Sheet
Last Updated: October 10, 2025, 1:44 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 | 43 |
| Reserves | 1,207 | 1,119 | 1,073 | 1,059 | 1,301 | 1,370 | 1,201 | 1,743 | 2,293 | 2,658 | 3,180 | 3,614 |
| Borrowings | 1,067 | 1,600 | 1,349 | 1,275 | 868 | 912 | 822 | 286 | 122 | 106 | 156 | 157 |
| Other Liabilities | 1,717 | 1,406 | 1,311 | 1,498 | 1,635 | 1,524 | 2,764 | 3,072 | 3,652 | 3,758 | 3,853 | 4,517 |
| Total Liabilities | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 |
| Fixed Assets | 526 | 1,351 | 1,289 | 1,222 | 1,117 | 957 | 965 | 817 | 763 | 793 | 759 | 694 |
| CWIP | 792 | 74 | 55 | 33 | 27 | 42 | 23 | 53 | 100 | 19 | 61 | 84 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 213 |
| Other Assets | 2,716 | 2,743 | 2,433 | 2,619 | 2,702 | 2,850 | 3,842 | 4,274 | 5,247 | 5,753 | 6,413 | 7,339 |
| Total Assets | 4,034 | 4,168 | 3,777 | 3,875 | 3,846 | 3,849 | 4,830 | 5,144 | 6,110 | 6,565 | 7,233 | 8,330 |
Below is a detailed analysis of the balance sheet data for BASF India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 43.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 43.00 Cr..
- For Reserves, as of Mar 2025, the value is 3,614.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,180.00 Cr. (Mar 2024) to 3,614.00 Cr., marking an increase of 434.00 Cr..
- For Borrowings, as of Mar 2025, the value is 157.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 156.00 Cr. (Mar 2024) to 157.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 4,517.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,853.00 Cr. (Mar 2024) to 4,517.00 Cr., marking an increase of 664.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 8,330.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,233.00 Cr. (Mar 2024) to 8,330.00 Cr., marking an increase of 1,097.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 694.00 Cr.. The value appears to be declining and may need further review. It has decreased from 759.00 Cr. (Mar 2024) to 694.00 Cr., marking a decrease of 65.00 Cr..
- For CWIP, as of Mar 2025, the value is 84.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2024) to 84.00 Cr., marking an increase of 23.00 Cr..
- For Investments, as of Mar 2025, the value is 213.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 213.00 Cr., marking an increase of 213.00 Cr..
- For Other Assets, as of Mar 2025, the value is 7,339.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,413.00 Cr. (Mar 2024) to 7,339.00 Cr., marking an increase of 926.00 Cr..
- For Total Assets, as of Mar 2025, the value is 8,330.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,233.00 Cr. (Mar 2024) to 8,330.00 Cr., marking an increase of 1,097.00 Cr..
Notably, the Reserves (3,614.00 Cr.) exceed the Borrowings (157.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 283.00 | 132.00 | 106.00 | 270.00 | -522.00 | -747.00 | -543.00 | 347.00 | 789.00 | 581.00 | 734.00 | 590.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 72 | 80 | 77 | 71 | 63 | 68 | 79 | 73 | 63 | 67 | 60 |
| Inventory Days | 136 | 106 | 85 | 93 | 94 | 99 | 93 | 73 | 66 | 71 | 68 | 80 |
| Days Payable | 138 | 98 | 117 | 120 | 117 | 103 | 133 | 126 | 112 | 108 | 114 | 118 |
| Cash Conversion Cycle | 69 | 80 | 49 | 50 | 48 | 59 | 28 | 25 | 26 | 26 | 21 | 23 |
| Working Capital Days | 49 | 43 | 43 | 36 | 28 | 32 | 10 | 26 | 34 | 37 | 44 | 40 |
| ROCE % | 12% | 0% | -2% | 5% | 9% | 1% | 6% | 23% | 34% | 20% | 25% | 18% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Tata Small Cap Fund | 763,051 | 4 | 251.76 | 763,051 | 2025-04-22 17:25:40 | 0% |
| Tata Hybrid Equity Fund - Regular Plan | 310,000 | 2.77 | 102.28 | 310,000 | 2025-04-22 17:25:40 | 0% |
| Tata Large & Mid Cap Fund - Regular Plan | 250,942 | 1.25 | 82.8 | 250,942 | 2025-04-22 17:25:40 | 0% |
| Tata Large & Mid Cap Fund - Regular Plan | 250,942 | 1.25 | 82.8 | 250,942 | 2025-04-22 17:25:40 | 0% |
| ICICI Prudential Smallcap Fund | 112,260 | 0.5 | 37.04 | 112,260 | 2025-04-22 17:25:40 | 0% |
| ICICI Prudential Manufacturing Fund | 29,437 | 0.32 | 9.71 | 29,437 | 2025-04-22 17:25:40 | 0% |
| Motilal Oswal Nifty Microcap 250 Index Fund | 15,949 | 0.61 | 5.26 | 15,949 | 2025-04-22 17:25:40 | 0% |
| ICICI Prudential S&P BSE 500 ETF | 145 | 0.02 | 0.05 | 145 | 2025-04-22 17:25:40 | 0% |
| Groww Nifty Total Market Index Fund | 69 | 0.02 | 0.02 | 69 | 2025-04-22 17:25:40 | 0% |
| HDFC S&P BSE 500 Index Fund | 40 | 0.02 | 0.01 | 40 | 2025-04-22 17:25:40 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Diluted EPS (Rs.) | 115.30 | 130.10 | 93.10 | 137.40 | 127.70 |
| Cash EPS (Rs.) | 156.38 | 174.30 | 135.13 | 176.81 | 167.83 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 844.79 | 744.65 | 623.97 | 539.63 | 412.60 |
| Dividend / Share (Rs.) | 20.00 | 15.00 | 8.00 | 6.00 | 10.00 |
| Revenue From Operations / Share (Rs.) | 3502.51 | 3180.29 | 3151.95 | 3026.04 | 2207.98 |
| PBDIT / Share (Rs.) | 190.97 | 223.07 | 167.26 | 216.08 | 150.00 |
| PBIT / Share (Rs.) | 149.91 | 178.91 | 125.20 | 176.68 | 109.83 |
| PBT / Share (Rs.) | 154.75 | 175.32 | 125.53 | 175.54 | 194.03 |
| Net Profit / Share (Rs.) | 115.32 | 130.13 | 93.07 | 137.41 | 127.65 |
| PBDIT Margin (%) | 5.45 | 7.01 | 5.30 | 7.14 | 6.79 |
| PBIT Margin (%) | 4.27 | 5.62 | 3.97 | 5.83 | 4.97 |
| PBT Margin (%) | 4.41 | 5.51 | 3.98 | 5.80 | 8.78 |
| Net Profit Margin (%) | 3.29 | 4.09 | 2.95 | 4.54 | 5.78 |
| Return on Networth / Equity (%) | 13.65 | 17.47 | 14.91 | 25.46 | 30.93 |
| Return on Capital Employeed (%) | 16.85 | 22.73 | 18.99 | 30.89 | 24.40 |
| Return On Assets (%) | 5.99 | 7.78 | 6.13 | 9.73 | 10.74 |
| Asset Turnover Ratio (%) | 1.95 | 2.00 | 2.15 | 2.33 | 1.96 |
| Current Ratio (X) | 1.55 | 1.59 | 1.47 | 1.37 | 1.27 |
| Quick Ratio (X) | 0.92 | 1.04 | 0.87 | 0.83 | 0.78 |
| Inventory Turnover Ratio (X) | 6.18 | 2.09 | 2.27 | 2.23 | 1.81 |
| Dividend Payout Ratio (NP) (%) | 13.00 | 6.14 | 6.44 | 7.27 | 2.35 |
| Dividend Payout Ratio (CP) (%) | 9.59 | 4.58 | 4.43 | 5.65 | 1.78 |
| Earning Retention Ratio (%) | 87.00 | 93.86 | 93.56 | 92.73 | 97.65 |
| Cash Earning Retention Ratio (%) | 90.41 | 95.42 | 95.57 | 94.35 | 98.22 |
| Interest Coverage Ratio (X) | 53.17 | 62.18 | 52.05 | 53.54 | 17.28 |
| Interest Coverage Ratio (Post Tax) (X) | 30.75 | 37.27 | 28.86 | 34.33 | 5.01 |
| Enterprise Value (Cr.) | 18377.30 | 13821.16 | 9498.38 | 13225.93 | 8803.28 |
| EV / Net Operating Revenue (X) | 1.21 | 1.00 | 0.69 | 1.01 | 0.92 |
| EV / EBITDA (X) | 22.23 | 14.31 | 13.12 | 14.14 | 13.56 |
| MarketCap / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| Retention Ratios (%) | 86.99 | 93.85 | 93.55 | 92.72 | 97.64 |
| Price / BV (X) | 5.25 | 4.48 | 3.65 | 5.72 | 5.03 |
| Price / Net Operating Revenue (X) | 1.27 | 1.05 | 0.72 | 1.02 | 0.93 |
| EarningsYield | 0.02 | 0.03 | 0.04 | 0.04 | 0.06 |
After reviewing the key financial ratios for BASF India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Diluted EPS (Rs.), as of Mar 25, the value is 115.30. This value is within the healthy range. It has decreased from 130.10 (Mar 24) to 115.30, marking a decrease of 14.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 156.38. This value is within the healthy range. It has decreased from 174.30 (Mar 24) to 156.38, marking a decrease of 17.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 844.79. It has increased from 744.65 (Mar 24) to 844.79, marking an increase of 100.14.
- For Dividend / Share (Rs.), as of Mar 25, the value is 20.00. This value exceeds the healthy maximum of 3. It has increased from 15.00 (Mar 24) to 20.00, marking an increase of 5.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3,502.51. It has increased from 3,180.29 (Mar 24) to 3,502.51, marking an increase of 322.22.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 190.97. This value is within the healthy range. It has decreased from 223.07 (Mar 24) to 190.97, marking a decrease of 32.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is 149.91. This value is within the healthy range. It has decreased from 178.91 (Mar 24) to 149.91, marking a decrease of 29.00.
- For PBT / Share (Rs.), as of Mar 25, the value is 154.75. This value is within the healthy range. It has decreased from 175.32 (Mar 24) to 154.75, marking a decrease of 20.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 115.32. This value is within the healthy range. It has decreased from 130.13 (Mar 24) to 115.32, marking a decrease of 14.81.
- For PBDIT Margin (%), as of Mar 25, the value is 5.45. This value is below the healthy minimum of 10. It has decreased from 7.01 (Mar 24) to 5.45, marking a decrease of 1.56.
- For PBIT Margin (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has decreased from 5.62 (Mar 24) to 4.27, marking a decrease of 1.35.
- For PBT Margin (%), as of Mar 25, the value is 4.41. This value is below the healthy minimum of 10. It has decreased from 5.51 (Mar 24) to 4.41, marking a decrease of 1.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 5. It has decreased from 4.09 (Mar 24) to 3.29, marking a decrease of 0.80.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.65. This value is below the healthy minimum of 15. It has decreased from 17.47 (Mar 24) to 13.65, marking a decrease of 3.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.85. This value is within the healthy range. It has decreased from 22.73 (Mar 24) to 16.85, marking a decrease of 5.88.
- For Return On Assets (%), as of Mar 25, the value is 5.99. This value is within the healthy range. It has decreased from 7.78 (Mar 24) to 5.99, marking a decrease of 1.79.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.95. It has decreased from 2.00 (Mar 24) to 1.95, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 1.55, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.04 (Mar 24) to 0.92, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.18. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 6.18, marking an increase of 4.09.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 13.00. This value is below the healthy minimum of 20. It has increased from 6.14 (Mar 24) to 13.00, marking an increase of 6.86.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 9.59. This value is below the healthy minimum of 20. It has increased from 4.58 (Mar 24) to 9.59, marking an increase of 5.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 87.00. This value exceeds the healthy maximum of 70. It has decreased from 93.86 (Mar 24) to 87.00, marking a decrease of 6.86.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 90.41. This value exceeds the healthy maximum of 70. It has decreased from 95.42 (Mar 24) to 90.41, marking a decrease of 5.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 53.17. This value is within the healthy range. It has decreased from 62.18 (Mar 24) to 53.17, marking a decrease of 9.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 30.75. This value is within the healthy range. It has decreased from 37.27 (Mar 24) to 30.75, marking a decrease of 6.52.
- For Enterprise Value (Cr.), as of Mar 25, the value is 18,377.30. It has increased from 13,821.16 (Mar 24) to 18,377.30, marking an increase of 4,556.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.00 (Mar 24) to 1.21, marking an increase of 0.21.
- For EV / EBITDA (X), as of Mar 25, the value is 22.23. This value exceeds the healthy maximum of 15. It has increased from 14.31 (Mar 24) to 22.23, marking an increase of 7.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For Retention Ratios (%), as of Mar 25, the value is 86.99. This value exceeds the healthy maximum of 70. It has decreased from 93.85 (Mar 24) to 86.99, marking a decrease of 6.86.
- For Price / BV (X), as of Mar 25, the value is 5.25. This value exceeds the healthy maximum of 3. It has increased from 4.48 (Mar 24) to 5.25, marking an increase of 0.77.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.05 (Mar 24) to 1.27, marking an increase of 0.22.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in BASF India Ltd:
- Net Profit Margin: 3.29%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.85% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.65% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 30.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.92
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 46.8 (Industry average Stock P/E: 405.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.29%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Unit Nos. 10A, 10B, 10C (Part), 10th Floor, Godrej One, Pirojshanagar, Mumbai Maharashtra 400079 | investor-grievance-india@basf.com http://www.basf.com/in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Pradip P Shah | Chairman |
| Mr. Alexander Gerding | Managing Director |
| Mr. Anil Choudhary | Whole Time Director |
| Dr. Ramkumar Dhruva | Director |
| Mrs. Shyamala Gopinath | Director |
| Mr. Marcelo Rocha Lu | Director |
| Mr. Bahram Vakil | Director |
| Ms. Sonia Singh | Director |
| Mr. Narendranath J Baliga | Whole Time Director |
| Mr. Manohar Kamath | Director - Legal |
FAQ
What is the intrinsic value of BASF India Ltd?
BASF India Ltd's intrinsic value (as of 09 November 2025) is 4353.75 which is 2.14% lower the current market price of 4,449.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 19,256 Cr. market cap, FY2025-2026 high/low of 8,160/4,065, reserves of ₹3,614 Cr, and liabilities of 8,330 Cr.
What is the Market Cap of BASF India Ltd?
The Market Cap of BASF India Ltd is 19,256 Cr..
What is the current Stock Price of BASF India Ltd as on 09 November 2025?
The current stock price of BASF India Ltd as on 09 November 2025 is 4,449.
What is the High / Low of BASF India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of BASF India Ltd stocks is 8,160/4,065.
What is the Stock P/E of BASF India Ltd?
The Stock P/E of BASF India Ltd is 46.8.
What is the Book Value of BASF India Ltd?
The Book Value of BASF India Ltd is 845.
What is the Dividend Yield of BASF India Ltd?
The Dividend Yield of BASF India Ltd is 0.45 %.
What is the ROCE of BASF India Ltd?
The ROCE of BASF India Ltd is 18.0 %.
What is the ROE of BASF India Ltd?
The ROE of BASF India Ltd is 13.7 %.
What is the Face Value of BASF India Ltd?
The Face Value of BASF India Ltd is 10.0.